Skip to main content

Table 2 IDH1 mutation status of secondary GBM samples

From: Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs

Patient ID

Treatment

IDH1

P1

–

Mutated

P2

–

Mutated

P3

–

Mutated

P4

–

Mutated

P5

TMZ

Mutated

P6

TMZ

Mutated

P7

TMZ

Mutated

P8

TMZ

Wild-type